TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Feb 22, 2023 2:01pm
111 Views
Post# 35298887
RE:RE:Causing Implausible Speculation, With No Responsibilty
RE:RE:Causing Implausible Speculation, With No Responsibiltyhomerun2010 wrote: Bet on the jockey not the horse
We have no jockey
There was actually no horse. We know Rathjen can ride a horse to victory. We've seen it with Carina which has raised significant institutional money and has received the 'green light' for human clinical trials.We know that BTI has a platform of value as validated by the US$200 million in potential milestone payments plus royalties to multiple parties, the J&J option, and that Cresence and Midatech valued the technology after due diligence. Ladenberg Thalmann and Armistice Capital also value xB3.
BTI has simply needed a horse to ride. Herceptin was a dead-end. BTI hasn't had money. It takes time to give birth to a new horse and Rathjen is at it. Lysosomal Storage, neuroinflammation, and neurodegeneration is the strategic focus and is validated by Chiesi. Rathjen aimed very big with Biodexa which was validated by Armistice.This company needs a complete recapitaliztion. It needs $US10 million to start moving forward. At $.02 it can be done. Raise as much as possible!